The true prevalence and penetrance of monogenic disease variants are often not known
because of clinical-referral ascertainment bias. We comprehensively assess the penetrance …

BACKGROUND Accurate penetrance of monogenic disorders is often unknown due to a
phenotype-first approach to genetic testing. Here, we use a genotype-first approach in four …

Obesity is a serious international health problem that increases the risk of several common
diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide …

beta-Cell transcription factor genes are important in the pathophysiology of the beta-cell, with
mutations in hepatocyte nuclear factor (HNF)-1alpha, HNF-4alpha, insulin promoter factor (…

OBJECTIVE—Common variation in the FTO gene is associated with BMI and type 2 diabetes.
Increased BMI is associated with diabetes risk factors, including raised insulin, glucose, …

Human geneticists are currently in the middle of a race. Thanks to a new technology in the
form of 'genome-wide chips', investigators can potentially find many novel disease genes in …

The genes ABCC8 and KCNJ11, which encode the subunits sulfonylurea receptor 1 (SUR1)
and inwardly rectifying potassium channel (Kir6.2) of the β-cell ATP-sensitive potassium (K …

Epidemiological studies consistently show that circulating sex hormone binding globulin (SHBG)
levels are lower in type 2 diabetes patients than non-diabetic individuals, but the causal …

Fibroblast growth factor 21 (FGF21) is a hormone that has insulin-sensitizing properties. Some
trials of FGF21 analogs show weight loss and lipid-lowering effects. Recent studies have …

Mutations in the hepatocyte nuclear factor–1α (HNF-1α) gene have recently been shown to
cause maturityonset diabetes of the young (MODY). We have examined 15 UK MODY …